Square Pharmaceuticals PLC. announcements
313 Dhaka Stock Exchange announcements for Square Pharmaceuticals PLC. (SQURPHARMA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2014 (13).
- Sponsors Buy/Sell/Transfer
Jahanara Chowdhury, one of the Sponsors of the Company, has further reported that she has completed her sale of 4,99,000 shares of the Company at prevailing market price through Stock Exchange as announced earlier. Jahanara Chowdhury, one of the Sponsors of the Company, has expressed her intention to transfer 27,00,000 shares out of her total holding of 28,00,007 shares of the Company to her daughters namely, Meher Parveen (9,00,000 shares), Shamima Nasreen (9,00,000 shares) and Muniza Karim (9,00,000 shares), by way of gift outside the trading system of the Exchange within next 30 working days from the date of issuance of approval letter by DSE.
- Q2 earnings
(H/Y): As per un-audited half yearly accounts as on 30.09.2014 (April'14 to Sep'14), the Company has reported consolidated net profit after tax (excluding non-controlling interests) of Tk. 2,692.67 million with consolidated EPS of Tk. 4.86 as against Tk. 2,515.49 million and Tk. 4.54 respectively for the same period of the previous year. Whereas consolidated net profit after tax (excluding non-controlling interests) was Tk. 1,303.78 million with consolidated EPS of Tk. 2.35 for the period of 3 months (July'14 to Sep'14) ended on 30.09.2014 as against Tk. 1,183.65 million and Tk. 2.14 respectively for the same period of the previous year.
- Sponsor/Director Share Sale
Jahanara Chowdhury, one of the Sponsors of the Company, has expressed her intention to sell 4,99,000 shares out of her total holding of 32,99,007 shares of the Company at prevailing market price through Stock Exchange (DSE) within next 30 working days.
- credited the bonus shares
The Company has informed that it has credited the bonus shares for the year ended on March 31, 2014 to the respective shareholders' BO Account on October 01, 2014.
- trade resume
Normal trading of the shares of the Company will resume on 27.08.2014 after record date.
- trade suspension
Trading of the shares of the Company will remain suspended on record date i.e., 26.08.2014.
- Spot Market Transaction
Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 24.08.2014 to 25.08.2014. Trading of the shares of the Company will remain suspended on record date i.e., 26.08.2014.
- Credit Rating
Credit Rating Information and Services Limited (CRISL) has rated the Company as "AA+" in the long term and "ST-1" in the short term in consideration of audited financials of the Company up to March 31, 2014 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Q1 Earnings
(Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th June 2014 (Apr'14 to June'14), the Company has reported consolidated profit after tax (excluding non-controlling interest) of Tk. 1,388.89 million with consolidated basic EPS of Tk. 2.88 as against Tk. 1,331.84 million and Tk. 2.76 respectively for the same period of the previous year. However, considering proposed bonus share @ 15% for the year 2014, consolidated restated basic EPS will be Tk. 2.51 as on 30.06.2014 and Tk. 2.40 as on 30.06.2013.
- recommended 30% cash and 15% stock dividend
The Board of Directors has recommended 30% cash dividend and 15% stock dividend for the year ended on March 31, 2014. Date of AGM: 25.09.2014, Time: 10:00 AM, Venue: Factory premises, Kaliakoir, Gazipur. Record Date: 26.08.2014. The Company has also reported NAV of Tk. 22,277.52 million, EPS of Tk. 8.36 and NOCFPS of Tk. 12.90 for the year ended on March 31, 2014.
- Board Meeting
As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will be held on July 17, 2014 at 2:30 PM to consider, among others, audited financial statements of the Company for the year ended on March 31, 2014.
- Q3 Earnings
As per un-audited quarterly accounts for the 3rd quarter ended on 31st December 2013 (Oct'13 to Dec'13), the Company has reported consolidated profit after tax (excluding non controlling interest) of Tk. 1,589.34 million with consolidated EPS of Tk. 3.30 as against Tk. 1,194.34 million and Tk. 2.48 respectively for the same period of the previous year. Whereas consolidated profit after tax (excluding non controlling interest) was Tk. 4,104.82 million with consolidated EPS of Tk. 8.52 for the period of nine months (Apr'13 to Dec'13) ended on 31.12.2013 as against Tk. 3,245.10 million and Tk. 6.73 respectively for the same period of the previous year.
- (Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st December 2013 (Oct'13 to Dec'13), the Compa
(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st December 2013 (Oct'13 to Dec'13), the Company has reported consolidated profit after tax (excluding non controlling interest) of Tk. 1,589.34 million with consolidated EPS of Tk. 3.30 as against Tk. 1,194.34 million and Tk. 2.48 respectively for the same period of the previous year. Whereas consolidated profit after tax (excluding non controlling interest) was Tk. 4,104.82 million with consolidated EPS of Tk. 8.52 for the period of nine months (Apr'13 to Dec'13) ended on 31.12.2013 as against Tk. 3,245.10 million and Tk. 6.73 respectively for the same period of the previous year.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.